Anti-leishmanial and cytotoxic activities of extracts from three Pakistani plants
Purpose: To evaluate the in vitro and in vivo anti-leishmanial and cytotoxic activities of extracts of different parts of Lawsonia Inermis, Morus nigra and Ziziphus mauritiana.
Methods: The methanol extracts of all three plant materials at concentrations of 10 - 100 μg/mL were tested for their in vitro anti-leishmanial effects on L. tropica KWH23 promastigotes for 24 - 48 h, relative to negative control and amphotericin-B (standard drug). For in vivo anti-leishmanial activity, the extracts were tested against L. tropica-infected albino mice, while cytotoxicity was investigated against mammalian cells (lymphocytes).
Results: For Lawsonia Inermis leaves, mean inhibition of extracellular promastigotes at 10, 25, 50 and 100 μg/mL after 48 h were 98.2 ± 0.06, 98.75 ± 1.09, 99.31 ± 0.00 and 100.00 ± 0.00 %, respectively. After 8 weeks, mean lesion size decreased from 0.8 ± 0.2 mm to 0.3 ± 0.1 mm (p < 0.01), and cure at 150 mg/kg against intracellular amastigotes in albino mice was 97.02 % (95 % CI = 96.14 - 98.10). IC50 for Lawsonia inermis leaf extract was 12.22 μg/mL (95 % CI = 11.54 - 13.84) against lymphocytes.
Conclusion: The results obtained in this study show that Lawsonia Inermis leaf is safe and possesses potent anti-leishmanial activity.
Keywords: Leishmania tropica, Lawsonia inermis, Morus Nigra, Ziziphus Mauritiana, Anti-leishmania, Amastigotes, Lymphocytes
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.